Drug Shortage Report for ACLASTA
| Report ID | 189213 |
| Drug Identification Number | 02269198 |
| Brand name | ACLASTA |
| Common or Proper name | ACLASTA |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100ML 1LIVI |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-11 |
| Estimated end date | 2023-05-12 |
| Actual end date | 2023-05-15 |
| Shortage status | Resolved |
| Updated date | 2023-05-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2023-05-16 | English | Compare |
| v8 | 2023-05-15 | French | Compare |
| v7 | 2023-05-15 | English | Compare |
| v6 | 2023-05-01 | French | Compare |
| v5 | 2023-05-01 | English | Compare |
| v4 | 2023-04-12 | English | Compare |
| v3 | 2023-04-11 | French | Compare |
| v2 | 2023-04-11 | English | Compare |
| v1 | 2023-04-11 | English | Compare |
Showing 1 to 9 of 9